Lates News

Hong Kong-listed innovative pharmaceutical concept stocks fluctuate and fall, with Chinese biopharmaceutical companies, Viya Biotechnology, and Fosun Pharma falling more than 4%, while Junshi Biosciences, Rongchang Biotechnology, and Xinda Biotechnology falling more than 3%.